The global shoulder arthroplasty market size reached USD 1.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.9 Billion by 2033, exhibiting a growth rate (CAGR) of 5.1% during 2025-2033. The market is propelled by the increasing incidence of shoulder arthritis, development of better implant materials, expanding indications for shoulder replacement procedures, rising population of geriatrics, and heightened consciousness of invasive surgeries.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 1.9 Billion |
Market Forecast in 2033
|
USD 2.9 Billion |
Market Growth Rate 2025-2033 | 5.1% |
Rising Aging Population and Joint Disorders
Rapid globalization and life expectancy are significant factors that have escalated the demand for shoulder arthroplasty. Moreover, this condition is experienced when people grow older and is characterized by a painful stiffening of the shoulder joint caused by osteoarthritis. For instance, the US Census Bureau predicts that in 2030 all baby boomers will be aged 65 years and above, thus increasing the incidences of musculoskeletal disorders. This demographic trend suggests increased utilization of shoulder arthroplasty procedures as a logical consequence. Furthermore, hospitals and governments are increasingly addressing these issues by focusing on joint replacement surgery and orthopaedic care to manage the rising population, thus stimulating shoulder arthroplasty market share.
Ongoing Technological Advancements
Advancements in implant materials and surgical approaches have transformed shoulder arthroplasty by positively impacting the patient’s results and subsequent rehabilitation. According to the National Institutes of Health (NIH), new technologies for the minimally invasive approach are growing at a rate of 15% per year and arthroscopic shoulder surgery is a good example of this category as it takes less time to heal than an open surgery. Modem diagnostic imaging techniques such as Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) scans assist in diagnosis and planning by providing increased sharpness in surgery. Along with this, advances in technology in 3D printing make it possible to offer customized implants for the best fit and performance of the same which in turn has escalated the shoulder arthroplasty demand. These enhance the quality of life for patients since the procedures decrease pain and enhance mobility. They are resources that attract research and development (R&D) investment to improve the shoulder arthroplasty market.
Escalating Sport Injuries
Increased incidence of sports activities, resulting in conditions like rotator cuff tears and shoulder dislocations, leads to an enhanced need for shoulder arthroplasty among young populations. For instance, the current research reveals that sports-related injuries are major causes of orthopedic visits; the USA experiences more than 8 million sports injury cases annually. Cyclists are among the personalities who may need the services of a surgeon to reconstruct their shoulders because of injury or repetitive strain that leads to pain or contraction. This shoulder arthroplasty market forecast is resulting in the development and adoption of surgery methodologies relevant especially for the sporting figure, including shoulder resurfacing and new tendon repair methods. With the increasing involvement of people in sports across the world, there is a growing need for orthopedic surgeons to offer surgeries such as shoulder arthroplasty, making it an important aspect of managing sporting activities associated with shoulder injuries.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on device, procedure, indication, and end user.
Breakup by Device:
The report has provided a detailed breakup and analysis of the market based on the device. This includes shoulder arthroplasty resurfacing implants, trauma devices, and platform systems.
Resurfacing implants offer an array of procedures of less invasive methods, shortening the recovery period to improve the overall results. Trauma devices are important for procedures concerning cases such as fractures and dislocations which pose challenges when treating and need to be well stabilized. Platform systems enhance top-notch materials and flexibility in operations, which are amendable and offer high accuracy for the long term. These innovations help to drive the market, and this is because the demand for better orthopedic solutions is on the rise globally. They also play a part in increasing the development of treatments in the operation room and in the rehabilitation, therefore benefiting general patient care and quality of life. In the context where healthcare providers and then patients consider new and efficient treatments as a top priority, these technologies remain instrumental in the advancement of shoulder arthroplasty in the international context.
Breakup by Procedure:
Revision shoulder arthroplasty holds the largest share of the industry
A detailed breakup and analysis of the market based on the procedure have also been provided in the report. This includes partial, total, and revision shoulder arthroplasty. According to the report, revision shoulder arthroplasty accounted for the largest market share.
Revision shoulder arthroplasty holds a relatively large shoulder arthroplasty market share as it is a procedure performed in case of complications or failures of the previous intervention. The U. S. National Institutes of Health (NIH) indicates that revision procedures contribute to roughly 20 % of total shoulder arthroplasty surgeries undertaken annually. This is a result of the rising number of primary total joint arthroplasty procedures and subsequent revision surgeries arising from implant complications, infections, as well as patients’ anatomy. The revision processes require intricate methods and individualized instrumentation that help patients regain functionality and experience a reduction in pain, thus promoting the need for better orthopedic services. This quirk is more beneficial for patients with complex cases, and hence the input of surgical specialists that focus on revision arthroplasty is constructive to the market. Consequently, as healthcare facilities focus on outcomes and quality of life, revision shoulder arthroplasty remains an important and growing aspect of orthopedic surgery internationally.
Breakup by Indication:
The report has provided a detailed breakup and analysis of the market based on the indication. This includes arthritis, fracture/dislocation, rotator cuff tear arthropathy, hill sachs defect, and others.
Arthritis is one of the most common diseases leading to shoulder pain and its treatment calls for joint replacement thus increasing the need for shoulder arthroplasty procedures. Injuries involving bone fractures and dislocations in trauma cases require surgery to stabilize and start the healing process, which upsurges orthopedic implants and devices market. Rotator cuff tear arthropathy is related to chronic shoulder instability requires surgical treatment for treatment and restoration of functioning. In shoulder instability cases, Hill-Sachs defects are common; they are characterized by bone deformities which also need specialized implant designs and procedures to avoid recurrent dislocations. Collectively, these indications drive market advancement by fostering technological advancements regarding surgical methods, implant technologies, and rehabilitation processes, catering to patients’ various needs and enhancing the outcomes of shoulder arthroplasty worldwide.
Breakup by End User:
Hospitals exhibit a clear dominance in the market
A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals, orthopedic centers, ambulatory surgical centers, and others. According to the report, hospitals accounted for the largest market share.
As per shoulder arthroplasty industry overview, hospitals account for the largest share of the market owing to their broader framework, and medical facilities. According to data from the Centers for Medicare & Medicaid Services (CMS), hospitals account for approximately 65% of the total shoulder arthroplasty procedures performed annually in the United States alone. This position is backed by the increased facility of hospitals in dealing with complicated situations concerning intricate surgeries and subsequent theater care. They provide numerous orthopedic-related services, and some people present themselves for specialized procedures and treatments of chronic diseases such as arthritis, complications of fractures, and rotator cuff tears. Hospitals also enjoy the reality of preexisting structures which means there is a customer base or rather patients who would require the services of the orthopedic hospitals. They also are involved in research and training, which helps to grow and evolve the available shoulder arthroplasty procedures and tools. Thus, this approach integrates the shoulder arthroplasty market and puts the hospitals at the center of translating the need and demand for shoulder arthroplasty products across the globe.
Breakup by Region:
North America leads the market, accounting for the largest shoulder arthroplasty market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa. According to the report, North America was the largest regional market for shoulder arthroplasty.
North America holds the largest share of the shoulder arthroplasty market on the back of several factors. The region has strong healthcare facilities, high healthcare expenditure, and ongoing technological advancements in orthopedic surgeries. According to data from the Centers for Medicare & Medicaid Services (CMS), North America holds approximately 55% of the global shoulder arthroplasty market share. This is further supported by an ageing population susceptible to joint ailments in the region as well as a rise in sportsmen and women with injuries that may only be treated through surgery. Furthermore, the innovation process regarding orthopedic equipment is fueled, primarily, by key players from the industry which has its headquarters mostly in North America and is constantly researching and developing new products for the market. Altogether they make North America a dominating market for shoulder arthroplasty and have immense involvement in determining the overall world market.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Devices Covered | Shoulder Arthroplasty Resurfacing Implants, Shoulder Arthroplasty Trauma Devices, Shoulder Arthroplasty Platform Systems |
Procedures Covered | Partial Shoulder Arthroplasty, Total Shoulder Arthroplasty, Revision Shoulder Arthroplasty |
Indications Covered | Arthritis, Fracture/Dislocation, Rotator Cuff Tear Arthropathy, Hill-Sachs Defect, Others |
End Users Covered | Hospitals, Orthopedic Centers, Ambulatory Surgical Centers, Others |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Arthrex Inc., BioTek Instruments Inc. (Agilent Technologies Inc.), Conmed Corporation, DJO Global (Colfax Corporation), Exactech Inc., Implantcast GmbH, Integra LifeSciences Corporation, Johnson & Johnson, Kinamed Incorporated, Limacorporate S.p.A., Medacta Group, Smith and Nephew Plc, Stryker Corporation, Zimmer Biomet, etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global shoulder arthroplasty market was valued at USD 1.9 Billion in 2024.
We expect the global shoulder arthroplasty market to exhibit a CAGR of 5.1% during 2025-2033.
The rising cases of inflammatory arthritis, osteonecrosis, and post-traumatic degenerative joint disease, causing shoulder pain and interfering with the everyday activities of the patients, are primarily driving the global shoulder arthroplasty market.
The sudden outbreak of the COVID-19 pandemic had led to the postponement of elective shoulder arthroplasty surgical procedures to minimize the risk of the coronavirus infection upon hospital visits or interaction with healthcare professionals and medical equipment.
Based on the procedure, the global shoulder arthroplasty market has been segmented into partial shoulder arthroplasty, total shoulder arthroplasty, and revision shoulder arthroplasty. Currently, revision shoulder arthroplasty procedure holds the majority of the total market share.
Based on the end user, the global shoulder arthroplasty market can be divided into hospitals, orthopedic centers, ambulatory surgical centers, and others. Among these, hospitals exhibit a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global shoulder arthroplasty market include Arthrex Inc., BioTek Instruments Inc. (Agilent Technologies Inc.), Conmed Corporation, DJO Global (Colfax Corporation), Exactech Inc., Implantcast GmbH, Integra LifeSciences Corporation, Johnson & Johnson, Kinamed Incorporated, Limacorporate S.p.A., Medacta Group, Smith and Nephew Plc, Stryker Corporation, and Zimmer Biomet.